Figure 1 - available via license: Creative Commons Attribution 2.0 Generic
Content may be subject to copyright.
ECG during onset of paroxysmal tachycardia. Narrow QRS wave tachycardia, 167 bpm, RP = 80ms, RP < PR. Arrows direct to P wave.  

ECG during onset of paroxysmal tachycardia. Narrow QRS wave tachycardia, 167 bpm, RP = 80ms, RP < PR. Arrows direct to P wave.  

Source publication
Article
Full-text available
Modification of atrioventricular node is a usual and necessary operation to cure atrioventricular nodal reentrant tachycardia (AVNRT). In this operation, atrioventricular block is the most severe complication and its prevention is of our great concern. This complication always occurs under some special circumstances with potential risk. So, it is v...

Context in source publication

Context 1
... showed normal heart structure and blood flow. Electrocardiogram (ECG) showed no abnormal appearance in sinus rhythm but displayed narrow QRS wave tachycardia when onset, 167 beats per minute (bpm) and RP = 80 ms, RP < PR [ Figure 1]. These symptoms combined with the clinical history, suggested us a possible Atrioventricular nodal reentrant tachycardia. ...

Similar publications

Article
Full-text available
Cardiac sarcoidosis is an uncommon cause of cardiac arrhythmias and cardiomyopathy. We describe a case of cardiac sarcoidosis presenting as an accelerated junctional rhythm and complete atrioventricular (AV) block, without severe left ventricular (LV) dysfunction or pulmonary symptoms. Computer tomography (CT) of the chest and mediastinal lymph nod...

Citations

Experiment Findings
Full-text available
Gemcitabine-Cisplatin chemotherapy is one of bladder cancer treatment available in Dr. Saiful Anwar General Hospital Malang, although chemotherapy are beneficent, it also gave many unwanted side effect. Body Mass Index (BMI) said to have roles in cancer development and therapy outcome. This study aimed to compare BMI with side effect incidence in bladder cancer patients receiving six course of Gemcitabine-Cisplatin chemotherapy. Eighteen bladder cancer patients receiving Gemcitabine-Cisplatin chemotherapy by urology oncologist from 2016 to 2018 were recorded. The patients were followed during their six series of chemotherapy and any possible side effect were recorded. The data then analysed with chi square and T-test using SPSS programme. Body mass index (BMI) including normal weight, underweight, overweight and obese, account to 73.3%; 6.67%; 13.3%; and 6.67% respectively. Pathology finding consist of Transitional Cell Carcinoma high grade (46.7%) and low grade (53.3%). All 15 patients underwent six series of Gemcitabine-Cisplatin chemotherapy, side effects occurred during the whole series including, nausea(80%), fatigue(87%), vomiting(27%), alopecia(13.3%), infection(20%). Hematologic side effect including anemia, leucopenia, thrombocytopenia and nephrotoxicity Hematologic side effects such as: anemia, leucopenia and thrombocytopenia and also nephrotoxicity occurred in all 15 patients, minimally once of the six series of chemotherapy. When those side effect compared with BMI there were no statistical significant between the them with (p = 0.360), (p = 0.310), (p = 0.634), and (p = 0.423) respectively. Body Mass Index has no relation with side effect occurrence in bladder cancer patients receiving Gemcitabine-Cisplatin chemotherapy.
Article
Full-text available
ABSTRACT Background: The study was aimed to review the commonly prescribed drugs for elderly in Middle East (ME) and to assess the protocol used for elderly with polypharmacy in Middle ME East comparing to the US protocol. Methods: Two hundred and fifty patients aged ≥ 40 years who are attended to different Hospitals were enrolled in this study. A history was taken for each patient including: name, gender, age, current drugs use, doses, using time (before or after meals), and duration of treatment with each drug. Statistical comparison of drugs prescribed for ME and US patients were established. Results: The percentage of drug prescription for certain drugs was higher in ME comparing to US, these include; cardiovascular drugs (P<0.001), Antibiotics/anti-invectives (P<0.001), Gastrointestinal tract (p<0.0001), Respiratory tract (p<0.0001), Dermatologic (P<0.01), Nutrients/supplements (P<0.001), Hypoglycemics (P<0.05), Steroids (P<0.0001), Anticoagulants (P<0.0001). Conclusion: The protocol used by the physicians in ME needs simple modification. Food- drug and drug-drug interaction was present and requires patient education and follow-up.